SHIJIAZHUANG SAGACITY NEW DRUG DEVELOPMENT CO., LTD

Patent Applications and Registrations

Patent applications and USPTO patent grants for SHIJIAZHUANG SAGACITY NEW DRUG DEVELOPMENT CO., LTD.The latest application filed is for "crystal form of wee1 inhibitor compound and use thereof".

Company Profile

10.9.13

SHIJIAZHUANG SAGACITY NEW DRUG DEVELOPMENT CO., LTD - Shijiazhuang, Hebei CN
Shijiazhuang Sagacity New Drug Development Co., Ltd. - Hebei CN
SHIJIAZHUANG SAGACITY NEW DRUG DEVELOPMENT COMPANY, LTD. - Shijiazhuang, Hebei CN
Shijiazhuang Sagacity New Drug Development Co., Ltd. - Shijiazhuang CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Crystal Form Of Wee1 Inhibitor Compound And Use Thereof App 20220220120 - QIAN; Wenyuan ; et al.	2022-07-14
Pyrimidine sulfamide derivative and preparation method and medical application thereof Grant 11,319,305 - Luo , et al. May 3, 2	2022-05-03
Medical Application Of Pyrimidine Sulfonamides Derivatives App 20210393627 - HE; Kunlun ; et al.	2021-12-23
Crystal form and salt form of pyridone compound and preparation method therefor Grant 11,198,686 - Zhang , et al. December 14, 2	2021-12-14
Medical Use Of Prostacyclin Receptor Agonist App 20210338665 - HE; Kunlun ; et al.	2021-11-04
S1p1 Agonist And Application Thereof App 20210300908 - WU; Lingyun ; et al.	2021-09-30
Crystal Form And Salt Form Of Pyridone Compound And Preparation Method Therefor App 20210206753 - ZHANG; Lei ; et al.	2021-07-08
Crystal Form Of 1h-imidazo[4,5-b]pyridine-2(3h)-one Compound And Preparation Process Therefor App 20210198253 - LEI; Maoyi ; et al.	2021-07-01
1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-one derivative as Wee1 inhibitor Grant 10,954,253 - Qian , et al. March 23, 2	2021-03-23
Atr Inhibitor And Application Thereof App 20200399260 - QIAN; Wenyuan ; et al.	2020-12-24
Crystal And Salt Forms Of Tricyclic Compound And Preparation Process Thereof App 20200339553 - ZHANG; Peng ; et al.	2020-10-29
Macrocyclic Compound Serving As Wee1 Inhibitor And Applications Thereof App 20200325145 - QIAN; Wenyuan ; et al.	2020-10-15
Pyrimidine Sulfamide Derivative And Preparation Method And Medical Application Thereof App 20200283425 - LUO; Yunfu ; et al.	2020-09-10
PDE4 inhibitor Grant 10,662,189 - Luo , et al.	2020-05-26
Pyridone derivative comprising heteroatomic ring butane substituent, for treating fibrosis and inflammatory diseases Grant 10,604,513 - Shih , et al.	2020-03-31
1,2-dihydro-3h-pyrazolo[3,4-d]pyrimidin-3-one Derivative As Wee1 Inhibitor App 20200017528 - QIAN; Wenyuan ; et al.	2020-01-16
Pde4 Inhibitor App 20190177318 - LUO; Yunfu ; et al.	2019-06-13
Pyridone Derivative Comprising Heteroatomic Ring Butane Substituent, For Treating Fibrosis And Inflammatory Diseases App 20190062315 - SHIH; Neng-yang ; et al.	2019-02-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.